Catalyst Wire Dossier Catalyst Wire Dossier

GM604

· Genervon Biopharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GM604, covering 2021-04-27 to 2021-04-27. Get the full timeline:

Most recent: Clinical Trial Update: GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) [Phase 2]

See pricing